000			01927 a2200481 4500
005			20250517144604.0
264		0	_c20190405
008			201904s 0 0 eng d
022			_a1473-5709
024	7		_a10.1097/CEJ.0000000000000345 _2doi
040			_aNLM _beng _cNLM
100	1		_aKabra, Aashish
245	0	0	_aHormonal manipulation with finasteride or oral contraception does not influence incidence of renal cell carcinoma. _h[electronic resource]
260			_bEuropean journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) _c09 2018
300			_a449-452 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial
650	0	4	_a5-alpha Reductase Inhibitors _xtherapeutic use
650	0	4	_aAged
650	0	4	_aCarcinoma, Renal Cell _xepidemiology
650	0	4	_aColorectal Neoplasms _xdiagnosis
650	0	4	_aContraception _xadverse effects
650	0	4	_aContraceptives, Oral _xadministration & dosage
650	0	4	_aDutasteride _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aFinasteride _xtherapeutic use
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aIncidence
650	0	4	_aKidney Neoplasms _xepidemiology
650	0	4	_aLongitudinal Studies
650	0	4	_aLung Neoplasms _xdiagnosis
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOvarian Neoplasms _xdiagnosis
650	0	4	_aProstatic Hyperplasia _xdrug therapy
650	0	4	_aProstatic Neoplasms _xdiagnosis
650	0	4	_aRisk Factors
650	0	4	_aSelf Report _xstatistics & numerical data
700	1		_aGelfond, Jonathan
700	1		_aLiss, Michael A
773	0		_tEuropean journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) _gvol. 27 _gno. 5 _gp. 449-452
856	4	0	_uhttps://doi.org/10.1097/CEJ.0000000000000345 _zAvailable from publisher's website
999			_c27011740 _d27011740